STAT3 and cancer: Recent studies indicated that the activation of LIFR and downstream STAT3 signaling maintained breast cancer cells in a dormant state and that loss of the LIFR-STAT3 axis led to enhanced proliferation of cancer cells and to bone destruction (30).